{"@id":"https://bioecon.ru/technology/darpin-protein-drugs/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://bioecon.ru/technology/darpin-protein-drugs/","json":"https://bioecon.ru/api/v1/technology/darpin-protein-drugs/index.json"},"id":"darpin-protein-drugs","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/china-resources-pharmaceutical/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/loopworm/"]},"maturity":7,"name":"Белковые препараты на основе DARPin","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Рибосомный дисплей"},{"n":2,"title":"Мультидоменная сборка"},{"n":3,"title":"Микробная ферментация"},{"n":4,"title":"Увеличение периода полувыведения"}],"summary":"Искусственно спроектированные белки анкириновых повторов с пикомолярной аффинностью и высокой термостабильностью, служащие альтернативой классическим моноклональным антителам.","url":"/technology/darpin-protein-drugs/","verified":"2026-11-22"}